跳转到主要内容

Mortality Risk in Patients with Urological Malignancies and HIV Coinfection\: A Systematic Review and Meta-Analysis of Cohort Studies

癌症发生与治疗(英文) 2026 年第 4 卷第 5 期 393-401 页

DOI:10.1016/j.cpt.2026.02.003

11

作者人数

0

被引次数

来源:Crossref,截至 2026-10-20

作者

  1. 1
    Yihang Zhang Yihang Zhang 第一作者
  2. 2
    Fei Zhao Fei Zhao
  3. 3
    Defu Yuan Defu Yuan
  4. 4
    Yueyu Huang Yueyu Huang
  5. 5
    Taiyi Jiang Taiyi Jiang
  6. 6
    Tong Zhang Tong Zhang
  7. 7
    Hao Wu Hao Wu
  8. 8
    Yu Zhang Yu Zhang
  9. 9
    An Zhao An Zhao
  10. 10
    Zhiqiang Zhu Zhiqiang Zhu
  11. 11
    Bin Su Bin Su

参考文献 共 54 条

  1. 1 Global burden of cancer attributable to HIV: a worldwide incidence analysis 10.1016/s2214-109x(25)00264-5
  2. 2 Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies 10.1016/s2352-3018(17)30066-8
  3. 3 Trends in life expectancy of HIV-infected patients receiving antiretroviral therapy — china, 2013–2023 10.46234/ccdcw2025.136
  4. 4 Elevated cancer-specific mortality among HIV-infected patients in the United States 10.1200/jco.2014.59.5967
  5. 5 Cancer statistics, 2025
  6. 6 Renal cell carcinoma associated with HIV/AIDS: a review of the epidemiology, risk factors, diagnosis, and treatment
  7. 7 Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis 10.1038/s41391-020-00268-2
  8. 8 Risk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States 10.1093/jnci/djy010
  9. 9 Clinical presentation and outcomes of prostate cancer in an urban cohort of predominantly African American, human immunodeficiency virus–infected patients 10.1016/j.urology.2014.09.054
  10. 10 Racial and ethnic disparities in prostate cancer—correlation with incidence and progression
  11. 11 Survival among HIV-infected and HIV-uninfected individuals with common Non–AIDS-Defining cancers 10.1158/1055-9965.epi-14-1079
  12. 12 Evolving epidemiology of HIV-associated malignancies 10.1097/coh.0000000000000327
  13. 13 HIV/AIDS-Associated malignancies of the urinary system (in Chinese)
  14. 14 Pyroptosis and its relationship with HIV-1 pathogenic mechanism (in Chinese)
  15. 15 Persistent expansion, in a human immunodeficiency virus-infected person, of V beta-restricted CD4+CD8+ T lymphocytes that express cytotoxicity-associated molecules and are committed to produce interferon-gamma and tumor necrosis factor-alpha 10.1086/515674
  16. 16 Cancer and HIV-1 infection: patterns of chronic antigen exposure 10.3389/fimmu.2020.01350
  17. 17 T cell exhaustion 10.1038/ni.2035
  18. 18 Altered mucosal immunity in HIV-positive colon adenoma: decreased CD4(+) T cell infiltration is correlated with nadir but not current CD4(+) T cell blood counts 10.1007/s10147-022-02188-8
  19. 19 PD-1 suppression enhances HIV reactivation and T-cell immunity via MAPK/NF-κB signaling 10.1186/s40001-025-02427-4
  20. 20 Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets 10.1084/jem.20151467
  21. 21 Lack of CD8(+) T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors 10.18632/oncotarget.27569
  22. 22 Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival 10.1097/qad.0000000000000780
  23. 23 T cell dysfunction and exhaustion in cancer 10.3389/fcell.2020.00017
  24. 24 Human immunodeficiency virus is associated with poor overall survival among patients with head and neck cancer 10.1093/cid/ciac924
  25. 25 Research progress on HPV infection in HIV-positive individuals
  26. 26 Screening for cancer in persons living with HIV infection 10.1016/j.trecan.2016.06.007
  27. 27 Synthesized HIV/AIDS Research Evidence. Social and structural determinants of health influencing HIV risk and participation across the HIV care cascade. Accessed 30 August 2025. https://hivevidence.org/social-and-structural-determinants-of-health-influencing-hiv-risk-and-participation-across-the-hiv
  28. 28 Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base 10.1002/cncr.32158
  29. 29 Cancer survival in people with AIDS: a population-based study from São Paulo, Brazil 10.1002/ijc.31081
  30. 30 HIV infection, cancer treatment regimens, and cancer outcomes among elderly adults in the United States 10.1001/jamaoncol.2019.1742
  31. 31 Long-term outcome of renal cell carcinoma in patients with HIV who undergo surgery 10.1186/s12879-022-07592-z
  32. 32 Prostate cancer presentation, treatment selection, and outcomes among men with HIV/AIDS: a clinical stage, race, and age-matched contemporary analysis 10.1016/j.urolonc.2020.07.027
  33. 33 Survival after cancer diagnosis in persons with AIDS 10.1097/01.qai.0000164033.02947.e3
  34. 34 Cancer and HIV: the molecular mechanisms of the deadly duo 10.3390/cancers16030546
  35. 35 Multicenter study of controlling nutritional status (CONUT) score as a prognostic factor in patients with HIV-related renal cell carcinoma 10.3389/fimmu.2021.778746
  36. 36 17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1
  37. 37 Changes of immune function and prognosis of patients with HIV/AIDS-associated nephropathy (in Chinese)
  38. 38 Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma 10.1038/s41421-022-00415-0
  39. 39 Succinate preserves CD8+ T cell fitness to augment antitumor immunity 10.1016/j.immuni.2025.07.017
  40. 40 Human immunodeficiency virus-related renal cell carcinoma: a 13.5-year experience 10.1186/s12981-025-00699-8
  41. 41 Reduced risk of prostate cancer in U.S. men with AIDS 10.1158/1055-9965.epi-10-0741
  42. 42 Factors influencing and management strategies for incomplete immune reconstitution following antiretroviral therapy in HIV-infected individuals and AIDS patients (in Chinese)
  43. 43 Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy 10.1056/nejmoa1110187
  44. 44 Analysis on the survival status and influencing factors of HIV/AIDS: a retrospective cohort study from 2000 to 2021 in Nanjing, China (in Chinese)
  45. 45 Pathogenesis of impaired immune reconstitution in human immunodeficiency virus-infected patients
  46. 46 Cancer treatment disparities in HIV-infected individuals in the United States 10.1200/jco.2013.54.8644
  47. 47 Association between autoimmunity-related disorders and prostate cancer: a Mendelian randomization study 10.1016/j.cpt.2024.03.002
  48. 48 Integrative analysis of cuproptosis-related lncRNAs: unveiling prognostic significance, immune microenvironment, and copper-induced mechanisms in prostate cancer 10.1016/j.cpt.2024.03.004
  49. 49 Cancer-associated fibroblasts promote enzalutamide resistance and PD-L1 expression in prostate cancer through CCL5-CCR5 paracrine axis 10.1016/j.isci.2024.109674
  50. 50 CCR5 receptor antagonists block metastasis to bone of v-Src oncogene–transformed metastatic prostate cancer cell lines 10.1158/0008-5472.can-14-0612
  51. 51 CD4/CD8 ratio and cancer risk among adults with HIV 10.1093/jnci/djac053
  52. 52 Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management 10.1016/j.cpt.2023.11.004
  53. 53 Mortality due to cancer treatment delay: systematic review and meta-analysis
  54. 54 Incidence and mortality of non-AIDS-defining cancers among people living with HIV: a systematic review and meta-analysis 10.1016/j.eclinm.2022.101613

数据来源

论文信息:
中华医学期刊网、Crossref、PubMed
作者名单:
Crossref
被引次数:
Crossref,截至 2026-10-20
参考文献:
Crossref

论文的著作权归作者与出版方所有,本站只整理公开的题录信息并附原文链接,不构成任何医疗建议。